{
    "Variants Include": [
      {
        "Gene": "LRRK2",
        "variants": [
          {
            "HGVS": "NM_198578.4:c.2803T>G",
            "cDNA Change": {
              "transcript": "NM_198578.4",
              "ref": "T",
              "alt": "G",
              "position": "2803T"
            },
            "Protein Change": {
              "ref": "S",
              "alt": "A",
              "position": "935"
            },
            "Description in input context": "S935A"
          },
          {
            "HGVS": "NM_198578.4:c.4321C>G",
            "cDNA Change": {
              "transcript": "NM_198578.4",
              "ref": "C",
              "alt": "G",
              "position": "4321"
            },
            "Protein Change": {
              "ref": "R",
              "alt": "G",
              "position": "1441"
            },
            "Description in input context": "R1441G"
          },
          {
            "HGVS": "NM_198578.4:c.5096A>G",
            "cDNA Change": {
              "transcript": "NM_198578.4",
              "ref": "A",
              "alt": "G",
              "position": "5096"
            },
            "Protein Change": {
              "ref": "Y",
              "alt": "C",
              "position": "1699"
            },
            "Description in input context": "Y1699C"
          },
          {
            "HGVS": "NM_198578.4:c.6055G>A",
            "cDNA Change": {
              "transcript": "NM_198578.4",
              "ref": "G",
              "alt": "A",
              "position": "6055"
            },
            "Protein Change": {
              "ref": "G",
              "alt": "S",
              "position": "2019"
            },
            "Description in input context": "G2019S"
          }
        ]
      }
    ],
    "Described Disease": {
      "Described Disease": "Parkinson disease",
      "MONDO": "MONDO:0005180"
    },
    "Experiment Method": [
      {
        "Assay Method": "Affinity purification and mass spectrometric analysis",
        "Material used": {
          "Material Source": "Mouse brain",
          "Material Name": "BAC transgenic mice",
          "Description": "FLAG-tagged LRRK2 protein was purified from BAC transgenic mice brain for phosphorylation site identification and binding protein analysis."
        },
        "Readout type": "Qualitative",
        "Readout description": [
          {
            "Variant": "NM_198578.4:c.2803T>G",
            "Conclusion": "Abnormal",
            "Molecular Effect": "complete loss-of function",
            "Result Description": "The S935A mutation abolished the interaction between LRRK2 and 14-3-3 proteins."
          },
          {
            "Variant": "NM_198578.4:c.4321C>G",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "The R1441G mutation reduced the binding of LRRK2 to 14-3-3 proteins and decreased the phosphorylation level at S935."
          },
          {
            "Variant": "NM_198578.4:c.5096A>G",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "The Y1699C mutation reduced the binding of LRRK2 to 14-3-3 proteins and decreased the phosphorylation level at S935."
          },
          {
            "Variant": "NM_198578.4:c.6055G>A",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "The G2019S mutation moderately reduced the binding of LRRK2 to 14-3-3 proteins and caused a modest decrease in S935 phosphorylation level in transgenic brain, though less significantly in cell culture."
          }
        ],
        "Biological replicates": {
          "Biological replicates": "Yes",
          "Description": "N.D."
        },
        "Technical replicates": {
          "Technical replicates": "Yes",
          "Description": "N.D."
        },
        "Basic positive control": {
          "Basic positive control": "Yes",
          "Description": "WT"
        },
        "Basic negative control": {
          "Basic negative control": "N.D.",
          "Description": "N.D."
        },
        "Validation controls P/LP": {
          "Validation controls P/LP": "N.D.",
          "Counts": "N.D."
        },
        "Validation controls B/LB": {
          "Validation controls B/LB": "N.D.",
          "Counts": "N.D."
        },
        "Statistical analysis method": {
          "Statistical analysis method": "Student's t-test (two-tailed)"
        },
        "Threshold for normal readout": {
          "Threshold for normal readout": "N.D.",
          "Source": "N.D."
        },
        "Threshold for abnormal readout": {
          "Threshold for abnormal readout": "N.D.",
          "Source": "N.D."
        },
        "Approved assay": {
          "Approved assay": "Yes"
        }
      },
      {
        "Assay Method": "Co-immunoprecipitation",
        "Material used": {
          "Material Source": "Cell line",
          "Material Name": "HEK293T",
          "Description": "HEK293T cells were transfected with different combinations of FLAG-LRRK2 and Myc-14-3-3 isoform plasmids for co-immunoprecipitation analysis."
        },
        "Readout type": "Qualitative",
        "Readout description": [
          {
            "Variant": "NM_198578.4:c.2803T>G",
            "Conclusion": "Abnormal",
            "Molecular Effect": "complete loss-of function",
            "Result Description": "The S935A mutation abolished the interaction between LRRK2 and 14-3-3 proteins."
          },
          {
            "Variant": "NM_198578.4:c.4321C>G",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "The R1441G mutation reduced the binding of LRRK2 to 14-3-3 proteins."
          },
          {
            "Variant": "NM_198578.4:c.5096A>G",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "The Y1699C mutation reduced the binding of LRRK2 to 14-3-3 proteins."
          },
          {
            "Variant": "NM_198578.4:c.6055G>A",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "The G2019S mutation reduced the binding of LRRK2 to 14-3-3 proteins."
          }
        ],
        "Biological replicates": {
          "Biological replicates": "Yes",
          "Description": "N.D."
        },
        "Technical replicates": {
          "Technical replicates": "Yes",
          "Description": "N.D."
        },
        "Basic positive control": {
          "Basic positive control": "Yes",
          "Description": "WT"
        },
        "Basic negative control": {
          "Basic negative control": "N.D.",
          "Description": "N.D."
        },
        "Validation controls P/LP": {
          "Validation controls P/LP": "N.D.",
          "Counts": "N.D."
        },
        "Validation controls B/LB": {
          "Validation controls B/LB": "N.D.",
          "Counts": "N.D."
        },
        "Statistical analysis method": {
          "Statistical analysis method": "Student's t-test (two-tailed)"
        },
        "Threshold for normal readout": {
          "Threshold for normal readout": "N.D.",
          "Source": "N.D."
        },
        "Threshold for abnormal readout": {
          "Threshold for abnormal readout": "N.D.",
          "Source": "N.D."
        },
        "Approved assay": {
          "Approved assay": "Yes"
        }
      },
      {
        "Assay Method": "GST-pull down assay",
        "Material used": {
          "Material Source": "Bacteria",
          "Material Name": "GST-14-3-3 isoform protein",
          "Description": "GST-14-3-3 isoform protein was expressed in bacteria with 100 mM IPTG induction for 4 hours at 37°C, and purified following the manufacturer’s instructions."
        },
        "Readout type": "Qualitative",
        "Readout description": [
          {
            "Variant": "NM_198578.4:c.2803T>G",
            "Conclusion": "Abnormal",
            "Molecular Effect": "complete loss-of function",
            "Result Description": "The S935A mutation abolished the interaction between LRRK2 and 14-3-3 proteins."
          },
          {
            "Variant": "NM_198578.4:c.4321C>G",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "The binding of 14-3-3 to mutant R1441G is markedly reduced as compared to wild-type LRRK2."
          },
          {
            "Variant": "NM_198578.4:c.5096A>G",
            "Conclusion": "Abnormal",
            "Molecular Effect": "partial loss-of-function",
            "Result Description": "The binding of 14-3-3 to mutant Y1699C is markedly reduced as compared to wild-type LRRK2."
          },
          {
            "Variant": "NM_198578.4:c.6055G>A",
            "Conclusion": "Normal",
            "Molecular Effect": "No Effect",
            "Result Description": "The binding of 14-3-3 to mutant G2019S showed no significant difference compared to wild-type LRRK2."
          }
        ],
        "Biological replicates": {
          "Biological replicates": "Yes",
          "Description": "N.D."
        },
        "Technical replicates": {
          "Technical replicates": "Yes",
          "Description": "N.D."
        },
        "Basic positive control": {
          "Basic positive control": "Yes",
          "Description": "WT"
        },
        "Basic negative control": {
          "Basic negative control": "N.D.",
          "Description": "N.D."
        },
        "Validation controls P/LP": {
          "Validation controls P/LP": "N.D.",
          "Counts": "N.D."
        },
        "Validation controls B/LB": {
          "Validation controls B/LB": "N.D.",
          "Counts": "N.D."
        },
        "Statistical analysis method": {
          "Statistical analysis method": "Student's t-test (two-tailed)"
        },
        "Threshold for normal readout": {
          "Threshold for normal readout": "N.D.",
          "Source": "N.D."
        },
        "Threshold for abnormal readout": {
          "Threshold for abnormal readout": "N.D.",
          "Source": "N.D."
        },
        "Approved assay": {
          "Approved assay": "Yes"
        }
      },
      {
        "Assay Method": "PKA kinase assay",
        "Material used": {
          "Material Source": "Bacteria",
          "Material Name": "GST-LRRK2 fragment",
          "Description": "GST-LRRK2 fragment (800–1000aa) was expressed in bacteria with 50 mM IPTG induction at RT for overnight and purified following the manufacturer’s instructions."
        },
        "Readout type": "Qualitative",
        "Readout description": [
          {
            "Variant": "NM_198578.4:c.2803T>G",
            "Conclusion": "N.D.",
            "Molecular Effect": "N.D.",
            "Result Description": "N.D."
          },
          {
            "Variant": "NM_198578.4:c.4321C>G",
            "Conclusion": "N.D.",
            "Molecular Effect": "N.D.",
            "Result Description": "N.D."
          },
          {
            "Variant": "NM_198578.4:c.5096A>G",
            "Conclusion": "N.D.",
            "Molecular Effect": "N.D.",
            "Result Description": "N.D."
          },
          {
            "Variant": "NM_198578.4:c.6055G>A",
            "Conclusion": "N.D.",
            "Molecular Effect": "N.D.",
            "Result Description": "N.D."
          }
        ],
        "Biological replicates": {
          "Biological replicates": "Yes",
          "Description": "N.D."
        },
        "Technical replicates": {
          "Technical replicates": "Yes",
          "Description": "N.D."
        },
        "Basic positive control": {
          "Basic positive control": "Yes",
          "Description": "PKA-mediated phosphorylation of GSK was used as a positive control."
        },
        "Basic negative control": {
          "Basic negative control": "N.D.",
          "Description": "N.D."
        },
        "Validation controls P/LP": {
          "Validation controls P/LP": "N.D.",
          "Counts": "N.D."
        },
        "Validation controls B/LB": {
          "Validation controls B/LB": "N.D.",
          "Counts": "N.D."
        },
        "Statistical analysis method": {
          "Statistical analysis method": "N.D."
        },
        "Threshold for normal readout": {
          "Threshold for normal readout": "N.D.",
          "Source": "N.D."
        },
        "Threshold for abnormal readout": {
          "Threshold for abnormal readout": "N.D.",
          "Source": "N.D."
        },
        "Approved assay": {
          "Approved assay": "Yes"
        }
      }
    ]
  }